Cargando…

Identification of Molecular Determinants of Primary and Metastatic Tumor Re-Initiation in Breast Cancer

Through in vivo selection of multiple ER-negative human breast cancer populations for enhanced tumor-forming capacity, we have derived sub-populations that generate tumors more efficiently than their parental populations at low cell numbers. Tumorigenic-enriched (TE) sub-populations displayed increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ross, Jason B., Huh, Doowon, Noble, Lisa B., Tavazoie, Sohail F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609531/ https://www.ncbi.nlm.nih.gov/pubmed/25866923 http://dx.doi.org/10.1038/ncb3148

Ejemplares similares

PTPRN2 and PLCβ1 promote metastatic breast cancer cell migration through PI(4,5)P(2)‐dependent actin remodeling
por: Sengelaub, Caitlin A, et al.
Publicado: (2015)

Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts
por: Fish, Lisa, et al.
Publicado: (2016)

Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness
por: Nguyen, Alexander, et al.
Publicado: (2016)

The AURORA initiative for metastatic breast cancer
por: Zardavas, D, et al.
Publicado: (2014)

Molecular determinants of metastatic transformation.
por: Egan, S E, et al.
Publicado: (1991)

Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers
por: Tikkanen, Antti, et al.
Publicado: (2020)

Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing
por: Boursault, Lucile, et al.
Publicado: (2013)

PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis
por: Yamaguchi, Norihiro, et al.
Publicado: (2019)

Identification of molecular determinants of antibiotic resistance in some fish farms of Ghana
por: Agbeko, Rosemary, et al.
Publicado: (2022)

Systematic assessment of prognostic molecular features across cancers
por: Santhanam, Balaji, et al.
Publicado: (2023)

Initial presentation and recurrence of metastatic rhabdomyosarcoma as breast mass
por: Nguyen, Ho V., et al.
Publicado: (2015)

Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study
por: Li, Yang, et al.
Publicado: (2021)

Primary lung carcinoid metastatic to the breast
por: Zagurovskaya, Marianna, et al.
Publicado: (2017)

Policies and innovations to battle Covid-19 – A case study of South Korea
por: Lee, Doowon, et al.
Publicado: (2020)

Extraocular Muscles Involvement as the Initial Presentation in Metastatic Breast Cancer
por: Coutinho, Inês, et al.
Publicado: (2018)

Enophthalmos as the Initial Systemic Finding of Undiagnosed Metastatic Breast Carcinoma
por: El-Khazen Dupuis, Jessica, et al.
Publicado: (2021)

Leucyl-tRNA synthetase is a tumour suppressor in breast cancer and regulates codon-dependent translation dynamics
por: Passarelli, Maria C., et al.
Publicado: (2022)

Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023)

A Case of Gastric Metastatic Melanoma 15 Years after the Initial Diagnosis of Cutaneous Melanoma
por: Farshad, Sohail, et al.
Publicado: (2018)

Arginine limitation causes a directed DNA sequence evolution response in colorectal cancer cells
por: Hsu, Dennis J., et al.
Publicado: (2023)

E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells
por: Palen, Katie, et al.
Publicado: (2016)

Tuberculosis: A re-emerging enemy
por: Sohail, M
Publicado: (2006)

Determining Factors Influencing RAS Inhibitors Re-Initiation in ICU: A Modified Delphi Method
por: Dahel, Hadjer, et al.
Publicado: (2022)

Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable
por: Ongaro, Elena, et al.
Publicado: (2019)

Morphological re-description and molecular identification of Tabanidae (Diptera) in East Africa
por: Mugasa, Claire M., et al.
Publicado: (2018)

RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
por: Zou, Denise, et al.
Publicado: (2021)

Effect of Hydrogen Annealing on Performances of BN-Based RRAM
por: Lee, Doowon, et al.
Publicado: (2023)

A case of a metastatic SDHA mutated paraganglioma re-presenting twenty-three years after initial surgery
por: Casey, Ruth T, et al.
Publicado: (2017)

Re-determination of the primary shelf-life of food products: what are the guarantees for the consumer?
por: Micheli, Massimo Renato, et al.
Publicado: (2023)

Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer
por: Inda, Márcia A., et al.
Publicado: (2021)

Human re-identification
por: Wu, Ziyan
Publicado: (2016)

Cutaneous involvement as the initial presentation of metastatic breast adenocarcinoma - Case report
por: de Siqueira, Verônica Riquet, et al.
Publicado: (2014)

Androgen receptor expression in metastatic adenocarcinoma in females favors a breast primary
por: Shidham, Vinod B, et al.
Publicado: (2006)

Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors
por: Palm, Christiane, et al.
Publicado: (2023)

Arginine limitation drives a directed codon-dependent DNA sequence evolution response in colorectal cancer cells
por: Hsu, Dennis J., et al.
Publicado: (2023)

Occult Breast Cancer Presenting as Metastatic Adenocarcinoma of Unknown Primary: Clinical Presentation, Immunohistochemistry, and Molecular Analysis
por: Wang, Jue, et al.
Publicado: (2012)

An integrated tool for determining the primary origin site of metastatic tumours
por: dos Santos, Marcos Tadeu, et al.
Publicado: (2018)

Medical device risk (re)classification: lessons from the FDA’s 515 Program Initiative
por: Mooghali, Maryam, et al.
Publicado: (2023)

Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data
por: Wang, Limei, et al.
Publicado: (2019)

Immunological barriers to immunotherapy in primary and metastatic breast cancer
por: De Martino, Mara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3qmshjn60pl0b0cd9dhimt3uma